SELLAS Life Sciences Group, Inc. — 424B3 Filings
31 424B3 filings on record
This page lists all 424B3 filings submitted to the SEC by SELLAS Life Sciences Group, Inc. (SLS), sorted by most recent first. Each row links to the full filing on EdgarLookup. SELLAS Life Sciences Group, Inc. has filed 31 424B3 documents with the SEC since 2011. To view all SEC filings by SELLAS Life Sciences Group, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424B2
424B3
424B4
424B5
425
5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
DEL AM
EFFECT
FWP
NO ACT
NT 10-K
NT 10-Q
POS AM
POS EX
PRE 14A
PRER14A
REGDEX
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 424B3 | 424B3 | 0001104659-20-072467 | Jun 11, 2020 | — |
| 424B3 | 424B3 | 0001193125-18-227881 | Jul 26, 2018 | — |
| 424B3 | 424B3 | 0001193125-18-227864 | Jul 26, 2018 | — |
| 424B3 | 424B3 | 0001193125-18-169711 | May 21, 2018 | — |
| 424B3 | 424B3 | 0001193125-17-370399 | Dec 15, 2017 | — |
| 424B3 | FORM 424B3 | 0001193125-17-357130 | Nov 30, 2017 | — |
| 424B3 | 424B3 | 0001193125-17-336114 | Nov 8, 2017 | — |
| 424B3 | 424B3 | 0001193125-16-742791 | Oct 20, 2016 | — |
| 424B3 | 424B3 | 0001193125-16-736759 | Oct 12, 2016 | — |
| 424B3 | 424B3 | 0001193125-15-413017 | Dec 23, 2015 | — |
| 424B3 | 424B3 | 0001193125-15-413008 | Dec 23, 2015 | — |
| 424B3 | 424B3 | 0001193125-15-412989 | Dec 23, 2015 | — |
| 424B3 | 424B3 | 0001193125-15-412966 | Dec 23, 2015 | — |
| 424B3 | 424B3 | 0001193125-14-208157 | May 21, 2014 | — |
| 424B3 | 424B3 | 0001193125-13-336807 | Aug 16, 2013 | — |
| 424B3 | 424B3 | 0001193125-12-304648 | Jul 17, 2012 | — |
| 424B3 | PROSPECTUS SUPPLIMENT | 0001193125-12-248723 | May 25, 2012 | — |
| 424B3 | 424(B)(3) | 0000950123-11-059538 | Jun 16, 2011 | — |
| 424B3 | RXI PHARMACEUTICALS CORPORATION | 0000950123-09-017224 | Jun 25, 2009 | — |
| 424B3 | RXI PHARMACEUTICALS CORPORATION | 0000950135-09-002275 | Mar 30, 2009 | — |
| 424B3 | RXI PHARMACEUTICALS CORPORATION | 0000950135-09-002274 | Mar 30, 2009 | — |
| 424B3 | RXI PHARMACEUTICALS CORPORATION - PROSPECTUS SUPPLEMENT NO.3 | 0000950135-08-007291 | Nov 14, 2008 | — |
| 424B3 | RXI PHARMACEUTICALS CORPORATION - PROSPECTUS SUPPLEMENT NO.2 | 0000950135-08-007290 | Nov 14, 2008 | — |
| 424B3 | RXI PHARMACEUTICALS CORPORATION | 0000950135-08-005601 | Aug 14, 2008 | — |
| 424B3 | RXI PHARMACEUTICALS CORPORATION | 0000950135-08-005600 | Aug 14, 2008 | — |
| 424B3 | RXI PHARMACEUTICALS CORPORATION | 0000950135-08-005386 | Aug 6, 2008 | — |
| 424B3 | RXI PHARMACEUTICALS CORPORATION 424(B)(3) | 0000950135-08-002719 | Apr 24, 2008 | — |
| 424B3 | RXI PHARMACEUTICALS CORPORATION | 0000950135-08-001716 | Mar 12, 2008 | — |
| 424B3 | RXI PHARMACEUTICALS CORPORATION | 0000950135-08-001714 | Mar 12, 2008 | — |
| 424B3 | RXI PHARMACEUTICALS CORPORATION | 0000950135-08-001712 | Mar 12, 2008 | — |
| 424B3 | RXI PHARMACEUTICALS CORPORATION | 0000950135-08-001585 | Mar 5, 2008 | — |